Mark E. Bunnage serves as EVP, Chief Scientific Officer at VERTEX PHARMACEUTICALS INC / MA, where they oversee executive responsibilities. Since joining the company, Mark E. Bunnage has executed 2 insider transactions totaling $301.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 25, 2026 involved selling 620 shares valued at $301.5K.
Mark E. Bunnage currently holds 7,284 shares of VERTEX PHARMACEUTICALS INC / MA (VRTX), valued at approximately $0. This represents their equity stake as EVP, Chief Scientific Officer.
Based on SEC Form 4 filings, Mark E. Bunnage has been a net seller of VRTX stock. They have purchased $0 and sold $301.5K worth of shares.
Mark E. Bunnage's most recent insider trade was on Feb 25, 2026, when they sold 620 shares at $486.35 per share.
Get notified when new Form 4 filings are submitted
| $485.11 |
| Discretionary |